methotrexate has been researched along with Shock, Cardiogenic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akyel, A; Cengel, A; Tacoy, G; Tavil, Y | 1 |
Hobbs, R; Tan, CD; Zardkoohi, O | 1 |
2 other study(ies) available for methotrexate and Shock, Cardiogenic
Article | Year |
---|---|
Patient with Takayasu arteritis presented as cardiogenic shock.
Topics: Antirheumatic Agents; Aorta; Blood Sedimentation; C-Reactive Protein; Echocardiography, Transesophageal; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Shock, Cardiogenic; Takayasu Arteritis; Time Factors | 2010 |
A rare shock.
Topics: Aged; Anti-Inflammatory Agents; Biopsy; Cardiac Catheterization; Churg-Strauss Syndrome; Coronary Angiography; Coronary Care Units; Diagnosis, Differential; Diuretics; Drug Therapy, Combination; Echocardiography; Electrocardiography; Endocardium; Eosinophilia; Female; Furosemide; Hemodynamics; Humans; Immunosuppressive Agents; Infusions, Intravenous; Methotrexate; Methylprednisolone; Myocardial Infarction; Myocardium; Nitroprusside; Prednisone; Shock, Cardiogenic; Vasodilator Agents | 2011 |